Division 3.4.2.1.2.3 F1
United Kingdom
The evidence referred to above could be:
- (a)
clinical history and data from appropriate lung function tests related to exposure to the substance, confirmed by other supportive evidence which may include:
- (i)
in vivo immunological test (e.g. skin prick test);
- (ii)
in vitro immunological test (e.g. serological analysis);
- (iii)
studies that indicate other specific hypersensitivity reactions where immunological mechanisms of action have not been proven, e.g. repeated low-level irritation, pharmacologically mediated effects;
- (iv)
a chemical structure related to substances known to cause respiratory hypersensitivity;
- (i)
- (b)
data from one or more positive bronchial challenge tests with the substance conducted according to accepted guidelines for the determination of a specific hypersensitivity reaction.